On Invalid Date, Kintara Therapeutics (NASDAQ: KTRA) reported Q4 2023 earnings per share (EPS) of -$0.24, up 88.57% year over year. Total Kintara Therapeutics earnings for the quarter were -$1.03 million. In the same quarter last year, Kintara Therapeutics's earnings per share (EPS) was -$2.10.
As of Q2 2024, Kintara Therapeutics's earnings has grown year over year. Kintara Therapeutics's earnings in the past year totalled -$10.77 million.
What is KTRA's earnings date?
Kintara Therapeutics's earnings date is Invalid Date. Add KTRA to your watchlist to be reminded of KTRA's next earnings announcement.
What was KTRA's revenue last quarter?
On Invalid Date, Kintara Therapeutics (NASDAQ: KTRA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Kintara Therapeutics's revenue was $0.00.
What was KTRA's revenue growth in the past year?
As of Q2 2024, Kintara Therapeutics's revenue has grown null year over year. Kintara Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.